Amylyx Pharmaceuticals, Inc. (AMLX)

SEC filing

Amylyx Pharmaceuticals, Inc.

AMLX · CIK 1658551

4 · Jan 20, 2026 · Klee Justin B. sold 138.19K shares at $13.59/share ($1.9M); exercised options for 200K shares

Klee Justin B. sold 138.19K shares at $13.59/share ($1.9M); exercised options for 200K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).